pharma
Celltrion’s infliximab biosimilar Remsima secures European approval in five indications
July 27, 2020Manufacturing and Production, Sales and Marketing celltrion, infliximab, pharma, remsima
The subcutaneous (SC) formulation of Remsima, Celltrion’s biosimilar version of infliximab, has secured approval from the European Commission covering five …
AstraZeneca partners with Daichii Sankyo in potential $6bn cancer drug deal
July 27, 2020Research and Development, Sales and Marketing AstraZeneca, Daiichi Sankyo, partnership, pharma
AstraZeneca and Daiichi Sankyo have joined forces to drive the development and commercialisation of the latter’s DS-1062, a trophoblast cell-surface …
UCB’s investigational IL-17A and IL-17F inhibitor outclasses Novartis’ Cosentyx in plaque psoriasis
July 24, 2020Medical Communications, Research and Development Cosentyx, UCB, pharma, psoriasis
UCB has revealed promising new data from a head-to-head trial pitting the company’s IL-17A and IL-17F inhibitor bimekizumab against Novartis’ …
Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study
July 22, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma
BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
AbbVie’s Rinvoq smashes Phase 3 efficacy targets in atopic dermatits
July 22, 2020Research and Development AbbVie, atopic dermatits, pharma, upadacitinib
AbbVie has lifted the curtain on data from the second Phase 3 trial investigating the efficacy of Rinvoq (upadacitinib) monotherapy …
Is Pharma doing enough on sustainability?
July 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability
Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
COVID-19 is pushing healthcare firms to embrace digital transformation, reports suggest
July 16, 2020Medical Communications, Research and Development digital, healthcare, pharma
The COVID-19 pandemic forced industries across the board to evolve or die with regard to their approach to digital working …
FDA committee backs GSK’s belantamab mafodotin in relapsed or refractory multiple myeloma
July 15, 2020Research and Development, Sales and Marketing Cancer, FDA, GSK, multiple myeloma, pharma
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has moved to recommend the use of GlaxoSmithKline’s belantamab mafodotin, or GSK2857916 as …
Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures
July 14, 2020Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma
Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …
Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance
July 10, 2020Medical Communications, Research and Development AMR, antimicrobial resistance, biotech, pharma
Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative of the International Federation of …
J&J under fire from 170 nonprofits to halt baby powder sales worldwide because it contains asbestos
July 9, 2020Sales and Marketing Cancer, J&J, JJ, pharma, talc
In the latest chapter in Johnson & Johnson’s talc-related woes, the company is being pressured by group of over 170 …
Takeda partners up with Carmine Therapeutics to develop and market rare disease candidates
July 1, 2020Research and Development Takeda Carmine, partnership, pharma
Takeda has linked up with Carmine Therapeutics in a new partnership to discover, develop and bring to market new non-viral …
The July/August 2020 issue of Pharmafocus is available to read free online now!
June 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma
The July/August 2020 issue of Pharmafocus is available to read free online now!
FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns
June 29, 2020Sales and Marketing AbbVie, Allergan, FDA, pharma
The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …
Gilead acquires 49.9% of Pionyer Therapeutics in potential $1.5bn+ deal
June 24, 2020Research and Development, Sales and Marketing Gilead, Pionyr, pharma
Gilead has announced its intention to acquire 49.9% of shares in cancer immunotherapy specialist Pionyr Therapeutics with a payment of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
